Heslop HE - Search Results

1

T-cell immunotherapy for adenoviral infections of stem-cell transplant recipients.

Leen AM, Myers GD, Bollard CM, Huls MH, Sili U, Gee AP, Heslop HE, Rooney CM. Leen AM, et al. Among authors: heslop he. Ann N Y Acad Sci. 2005 Dec;1062:104-15. doi: 10.1196/annals.1358.013. Ann N Y Acad Sci. 2005. PMID: 16461793 Review.

2

Gene transfer and bone marrow transplantation.

Brenner MK, Heslop HE, Rill D, Li C, Nilson T, Roberts M, Smith C, Krance R, Rooney C. Brenner MK, et al. Among authors: heslop he. Cold Spring Harb Symp Quant Biol. 1994;59:691-7. doi: 10.1101/sqb.1994.059.01.080. Cold Spring Harb Symp Quant Biol. 1994. PMID: 7587132 No abstract available.

3

Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease.

Smith CA, Ng CY, Heslop HE, Holladay MS, Richardson S, Turner EV, Loftin SK, Li C, Brenner MK, Rooney CM. Smith CA, et al. Among authors: heslop he. J Hematother. 1995 Apr;4(2):73-9. doi: 10.1089/scd.1.1995.4.73. J Hematother. 1995. PMID: 7633844

4

Gene marking after bone marrow transplantation.

Brenner MK, Rill DR, Heslop HE, Rooney CM, Roberts WM, Li C, Nilson T, Krance RA. Brenner MK, et al. Among authors: heslop he. Eur J Cancer. 1994;30A(8):1171-6. doi: 10.1016/0959-8049(94)90478-2. Eur J Cancer. 1994. PMID: 7654451 Review. No abstract available.

5

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation.

Rooney CM, Smith CA, Ng CY, Loftin S, Li C, Krance RA, Brenner MK, Heslop HE. Rooney CM, et al. Among authors: heslop he. Lancet. 1995 Jan 7;345(8941):9-13. doi: 10.1016/s0140-6736(95)91150-2. Lancet. 1995. PMID: 7799740

6

Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease.

Rooney CM, Loftin SK, Holladay MS, Brenner MK, Krance RA, Heslop HE. Rooney CM, et al. Among authors: heslop he. Br J Haematol. 1995 Jan;89(1):98-103. doi: 10.1111/j.1365-2141.1995.tb08904.x. Br J Haematol. 1995. PMID: 7833284

7

Donor T cells to treat EBV-associated lymphoma.

Heslop HE, Brenner MK, Rooney CM. Heslop HE, et al. N Engl J Med. 1994 Sep 8;331(10):679-80. doi: 10.1056/NEJM199409083311017. N Engl J Med. 1994. PMID: 8052285 No abstract available.

8

Correction of Duncan's syndrome by allogeneic bone marrow transplantation.

Williams LL, Rooney CM, Conley ME, Brenner MK, Krance RA, Heslop HE. Williams LL, et al. Among authors: heslop he. Lancet. 1993 Sep 4;342(8871):587-8. doi: 10.1016/0140-6736(93)91413-g. Lancet. 1993. PMID: 8102723

9

Epstein-Barr infection after bone marrow transplantation.

Heslop HE, Li C, Krance RA, Loftin SK, Rooney CM. Heslop HE, et al. Blood. 1994 Mar 15;83(6):1706-8. Blood. 1994. PMID: 8123864 Free article. No abstract available.

10

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes.

Heslop HE, Ng CY, Li C, Smith CA, Loftin SK, Krance RA, Brenner MK, Rooney CM. Heslop HE, et al. Nat Med. 1996 May;2(5):551-5. doi: 10.1038/nm0596-551. Nat Med. 1996. PMID: 8616714

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

423 results

Search Page

Filters